Validation of combinatorial probe–anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory

Ultrasound in Obstetrics and Gynecology

Volumn 50, Issue 1, 2017, Pages 49-57

  Ma, J ^a   Wang, Y ^b   Wang, W ^b,c   Dong, Y ^d   Xu, C ^e   Zhou, A ^f   Xu, Z ^g   Wu, Z ^h   Tang, X ⁱ   Chen, F ^b   Yin, Y ^b   Yan, M ^j   Zhang, W ^j   Mu, F ^j   Yang, H ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BGI SHENZHEN   (China)

^c Hubei Maternal and Child Health Hospital   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e Zhejiang University School of Medicine   (China)

^f Wuhan Municipal Healthcare Center for Women and Children   (China)

^g WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^h Guiyang Maternal and Child Health Hospital   (China)

ⁱ First People s Hospital of Yunnan Province   (China)

^j BGI Genomics Co Ltd ^*  (China)

more..

Author keywords

centralized mode; combinatorial probe anchor ligation based sequencer; cPAL; next generation sequencing; NIPT; non invasive prenatal testing; prenatal screening

Indexed keywords

ADOLESCENT; ADULT; CHINA; CHROMOSOME DISORDER; COMBINATORIAL CHEMISTRY; DOWN SYNDROME; EDWARDS SYNDROME; FEMALE; HUMAN; LABORATORY; MATERNAL SERUM SCREENING TEST; MIDDLE AGED; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; STANDARDS; TRISOMY 13; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; CHINA; CHROMOSOME DISORDERS; COMBINATORIAL CHEMISTRY TECHNIQUES; DOWN SYNDROME; FEMALE; HUMANS; LABORATORIES; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TRISOMY 13 SYNDROME; TRISOMY 18 SYNDROME; YOUNG ADULT;

EID: 85019738116     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.16010     Document Type: Article

References (20)

1. Surveillance CMaCH. Chinese Birth Defects surveillance system reporting guidelines of trobleshooting and minor malformation. http://www.mchscn.org/admin/wenjian/wxjxbgbZ-2012.pdf.
2. National Health and Family Planning Commission of the People's Republic of China. Chinese Birth Defects Prevention report. http://www.gov.cn/gzdt/2012-09/12/content_2223371.htm.
3. Bian XM, Jiang YL, Qi QW. Prenatal diagnosis, taking China's own path. Zhonghua Fu Chan Ke Za Zhi 2012; 47: 801–803.
4. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485–487.
5. Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, Lau TK, Xie J, Zhao W, Huang H, Xie J, Sun L, Zhang X, Wang W, Liao S, Qiang R, Cao J, Zhang Q, Zhou Y, Zhu H, Zhong M, Guo Y, Lin L, Gao Z, Yao H, Zhang H, Zhao L, Jiang F, Chen F, Jiang H, Li S, Li Y, Wang J, Wang J, Duan T, Su Y, Zhang X. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012; 32: 1225–1232.
6. BGI. Resolution of non-invasive prenatal test (NIFTY) of BGI. http://www.genomics.cn/BGI-Nifty/BGI-Nifty.html.
7. BerryGenomics. Clinical pratice of NIPT in BerryGenomics. http://www.berrygenomics.com/bambnitest/clinical/practice/.
8. China Food and Drug Administration (cFDA). Clinical test based on next generation sequencer was approved by cFDA. http://www.sfda.gov.cn/WS01/CL0051/102239.html.
9. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, Carnevali P, Nazarenko I, Nilsen GB, Yeung G, Dahl F, Fernandez A, Staker B, Pant KP, Baccash J, Borcherding AP, Brownley A, Cedeno R, Chen L, Chernikoff D, Cheung A, Chirita R, Curson B, Ebert JC, Hacker CR, Hartlage R, Hauser B, Huang S, Jiang Y, Karpinchyk V, Koenig M, Kong C, Landers T, Le C, Liu J, McBride CE, Morenzoni M, Morey RE, Mutch K, Perazich H, Perry K, Peters BA, Peterson J, Pethiyagoda CL, Pothuraju K, Richter C, Rosenbaum AM, Roy S, Shafto J, Sharanhovich U, Shannon KW, Sheppy CG, Sun M, Thakuria JV, Tran A, Vu D, Zaranek AW, Wu X, Drmanac S, Oliphant AR, Banyai WC, Martin B, Ballinger DG, Church GM, Reid CA. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010; 327: 78–81.
10. Jiang F, Ren J, Chen F, Zhou Y, Xie J, Dan S, Su Y, Xie J, Yin B, Su W, Zhang H, Wang W, Chai X, Lin L, Guo H, Li Q, Li P, Yuan Y, Pan X, Li Y, Liu L, Chen H, Xuan Z, Chen S, Zhang C, Zhang H, Tian Z, Zhang Z, Jiang H, Zhao L, Zheng W, Li S, Li Y, Wang J, Wang J, Zhang X. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics 2012; 5: 57.
11. Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, Zhu Z, Lin M, Liu Q, Tian Z, Zhang H, Chen F, Lau TK, Zhao L, Yi X, Yin Y, Wang W. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015; 45: 530–538.
12. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249–266.
13. Liao C, Yin AH, Peng CF, Fu F, Yang JX, Li R, Chen YY, Luo DH, Zhang YL, Ou YM, Li J, Wu J, Mai MQ, Hou R, Wu F, Luo H, Li DZ, Liu HL, Zhang XZ, Zhang K. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci U S A 2014; 111: 7415–7420.
14. Benn P, Borrell A, Chiu RW, Cuckle H, Dugoff L, Faas B, Gross S, Huang T, Johnson J, Maymon R, Norton M, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015; 35: 725–734.
15. Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, Zimmermann B, Hill M, Sigurjonsson S, Ryan A, Banjevic M, Kolacki PL, Koch SW, Strom CM, Rabinowitz M, Benn P. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014; 211: 527.e1–527.e17.
16. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013; 33: 569–574.
17. McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, Dharajiya N, Saldivar JS. Non-invasive prenatal chromosomal aneuploidy testing – clinical experience: 100,000 clinical samples. PLoS One 2014; 9: e109173.
18. Committee Opinion No. 640: Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015; 126: e31–e37.
19. Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, Chan HY, Chan WS, Choy KW. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol 2014; 43: 254–264.
20. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, Tomlinson MW, Pereira L, Spitz JL, Hollemon D, Cuckle H, Musci TJ, Wapner RJ. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372: 1589–1597.